In order to probe into the potential explanation to the enhanced effects of APOC4 rs1132899 polymorphism on early-onset CAD risk (≤60 years old), we further analyzed the association between APOC4 rs1132899 polymorphism and LDL-C, HDL-C, TC and TG levels. The gene discussed is APOC4; the disease is coronary artery disorder.